Mirion Technologies (NYSE:MIR) Reaches New 12-Month High – Should You Buy?

Mirion Technologies, Inc. (NYSE:MIR)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $17.09 and last traded at $17.00, with a volume of 163085 shares. The stock had previously closed at $16.87.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Citigroup increased their price objective on shares of Mirion Technologies from $17.00 to $18.00 and gave the stock a “buy” rating in a research note on Thursday, October 31st. The Goldman Sachs Group raised their price objective on shares of Mirion Technologies from $13.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, B. Riley initiated coverage on shares of Mirion Technologies in a report on Thursday, September 26th. They set a “buy” rating and a $14.00 target price on the stock.

Mirion Technologies Price Performance

The business’s 50 day moving average is $14.04 and its 200-day moving average is $11.76. The firm has a market capitalization of $3.95 billion, a P/E ratio of -49.62 and a beta of 0.73. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43.

Mirion Technologies (NYSE:MIR) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). The firm had revenue of $206.80 million during the quarter, compared to the consensus estimate of $203.67 million. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. The business’s revenue was up 8.2% compared to the same quarter last year. During the same period last year, the business earned $0.03 earnings per share. As a group, sell-side analysts predict that Mirion Technologies, Inc. will post 0.36 EPS for the current fiscal year.

Insider Activity at Mirion Technologies

In other news, CEO Thomas D. Logan sold 7,500 shares of Mirion Technologies stock in a transaction on Tuesday, September 24th. The shares were sold at an average price of $10.47, for a total transaction of $78,525.00. Following the transaction, the chief executive officer now owns 1,544,017 shares in the company, valued at approximately $16,165,857.99. The trade was a 0.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Emmanuelle Lee sold 3,405 shares of the business’s stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $14.27, for a total transaction of $48,589.35. The disclosure for this sale can be found here. Insiders have sold 23,405 shares of company stock valued at $285,939 over the last three months. 2.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Mirion Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Innealta Capital LLC bought a new stake in shares of Mirion Technologies during the second quarter worth about $39,000. Quest Partners LLC increased its position in shares of Mirion Technologies by 680.5% during the third quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock worth $74,000 after acquiring an additional 5,866 shares in the last quarter. SkyView Investment Advisors LLC bought a new stake in shares of Mirion Technologies during the third quarter worth about $111,000. Integrated Advisors Network LLC bought a new stake in Mirion Technologies in the 3rd quarter worth about $120,000. Finally, Paloma Partners Management Co bought a new stake in Mirion Technologies in the 3rd quarter worth about $122,000. 78.51% of the stock is owned by institutional investors.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.